Will it scale at the cost the plan assumes?
Titre, yield, downstream recovery, contract manufacturing and plant capacity, checked against the cost model in the deck.
Independent technical due diligence in food biotech and nutrition, for investment teams and corporate R&D in Europe and APAC. We read the data room, test the claims against published evidence and tell you what holds, what does not and what is still missing.
Titre, yield, downstream recovery, contract manufacturing and plant capacity, checked against the cost model in the deck.
Nutrition and health claims, novel food status and approval timelines in the EU, UK, US and APAC markets that matter to the deal.
A plain list of what has not been shown yet, and the questions to put to management before you commit.
Business engagements. EUR, excluding applicable taxes. Payment by invoice.
€4,900 fixed
It answers one narrow question: does the claim have evidence strong enough for the decision you are about to make?
€7,500 fixed
A desk-based review with a fixed scope, for a decision that cannot wait for a full study.
Quoted per case
For an investment or acquisition where the technology carries the deal.
€9,900, up to 8 people
For corporate teams who need to decide on a technology, a partner or a build-or-license question together. Two three-hour sessions within ten working days and a 3 to 5 page decision memo.
Every finding is written in three parts. Finding: what the evidence shows. Limit: what it cannot show, and how sure we are. Decision: what that means for your investment, licence or acquisition. We name every source, separate the company's own data from independent evidence and state the uncertainty in plain words. Where the evidence is not there, the memo says so.
The work is led by Dr Adam M. Adamek, Editor-in-Chief of FoodEdge.
Industry experience behind FoodEdge includes research and innovation leadership at Danone Research, consumer science and R&D leadership at Mondelēz International, R&D and nutrition innovation at Mars / foodspring, R&D and quality leadership at Pharma Nord, and market research and competitive intelligence at MSD (Merck & Co.).
Expert evaluation for REA / European Commission. Senior expert in evidence-based innovation at ClearGate Cambridge.
Startup Challenge judge at Fi Europe and Vitafoods.
We check conflicts before every engagement and name any relevant role in the engagement letter.